Literature DB >> 9735665

Antigenic diversity and serotypes of Helicobacter pylori associated with peptic ulcer diseases.

S M Park1, S I Hong, H Y Jung, S K Yang, H R Kim, Y I Min, W S Hong.   

Abstract

OBJECTIVES: Clinical presentation of Helicobacter pylori (H. pylori) infection has marked variation mainly due to the strain diversity and host susceptibility. Although H. pylori is identified as a major risk factor for gastric and duodenal ulcers, the ulcerogenic or pathogenic strain has not been documented yet. The objective of this study was to investigate antigenic types of the ulcerogenic strain of H. pylori.
METHODS: The sera of 64 patients were tested by Western blot using Helicoblot 2.0 for six major anti-H. pylori antibodies, together with CLO test and histological examination of gastric biopsy tissues. Thirty-five, nine and 20 patients had duodenal ulcer, gastric ulcer and chronic active gastritis, respectively. The antigenic types of H. pylori were analyzed in 54 patients with positive H. pylori infection. In this study, H. pylori was divided into four serotypes according to the presence and absence of CagA and VagA: type I; CagA (+) and VacA(+), type Ia: CagA (+) and VacA(-), type Ib: CagA(-) and VacA(+), and type II: CagA(-) and VacA(-).
RESULTS: There was no difference in the number of bands for six antigens: 3.2 +/- 1.4, 3.0 +/- 1.2 and 3.1 +/- 1.4 in 35 duodenal ulcer, 7 gastric ulcer and 12 chronic gastritis, respectively. The band with 119 kDa was 90.7%, which was the most common band with the order of 35, 30, 26.5, 89 and 19.5 kDa. Type I, la and Ib were positive in 22.2, 42.6 and 27.8%, respectively, which were significantly higher than type II (p < 0.05). There was no difference in the positive rates of four urease subtypes between the four serotypes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9735665      PMCID: PMC4531945          DOI: 10.3904/kjim.1998.13.2.104

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  23 in total

Review 1.  Helicobacter pylori: its role in disease.

Authors:  M J Blaser
Journal:  Clin Infect Dis       Date:  1992-09       Impact factor: 9.079

2.  Cytotoxin and urease activities of Helicobacter pylori isolates from Japanese patients with atrophic gastritis or duodenal ulcer.

Authors:  H Murakita; M Hirai; S Ito; T Azuma; T Kato; Y Kohli; M Kuriyama
Journal:  J Gastroenterol Hepatol       Date:  1996-09       Impact factor: 4.029

3.  Gastric lymphoma and Helicobacter pylori.

Authors:  P G Isaacson
Journal:  N Engl J Med       Date:  1994-05-05       Impact factor: 91.245

4.  Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States.

Authors:  S Miehlke; K Kibler; J G Kim; N Figura; S M Small; D Y Graham; M F Go
Journal:  Am J Gastroenterol       Date:  1996-07       Impact factor: 10.864

5.  Immunoglobulin G antibodies to Helicobacter pylori in patients with dyspeptic symptoms investigated by the western immunoblot technique.

Authors:  L P Andersen; F Espersen
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

6.  Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity.

Authors:  T L Cover; C P Dooley; M J Blaser
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

7.  Cure of duodenal ulcer associated with eradication of Helicobacter pylori.

Authors:  E A Rauws; G N Tytgat
Journal:  Lancet       Date:  1990-05-26       Impact factor: 79.321

8.  Local and systemic immune response in Helicobacter pylori-associated chronic gastritis before and after treatment.

Authors:  L Engstrand; S Gustavsson; A Schwan; A Scheynius
Journal:  Scand J Gastroenterol       Date:  1993-12       Impact factor: 2.423

Review 9.  Helicobacter pylori phenotypes associated with peptic ulceration.

Authors:  M J Blaser
Journal:  Scand J Gastroenterol Suppl       Date:  1994

10.  Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease.

Authors:  J L Telford; P Ghiara; M Dell'Orco; M Comanducci; D Burroni; M Bugnoli; M F Tecce; S Censini; A Covacci; Z Xiang
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

View more
  2 in total

1.  Antigenic diversity in Eimeria maxima and the influence of host genetics and immunization schedule on cross-protective immunity.

Authors:  Adrian L Smith; Patricia Hesketh; Andrew Archer; Martin W Shirley
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

2.  Clinical significance and usefulness of soluble heparin binding-epidermal growth factor in gastric cancer.

Authors:  Hye Won Chung; Hoon Young Kong; Jong-Baeck Lim
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.